Drug recall · April 3, 2024
Tri-Lo-Sprintec recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62
- Lots / codes
Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024
- Quantity
- 92,676 cartons
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- USA nationwide.
- Initiated
- March 7, 2024 · Voluntary: Firm initiated
- Classified
- March 28, 2024
- Reported
- April 3, 2024
- Ended
- March 6, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethinyl estradiol / norgestimate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.